Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris
Phase 4
Completed
Conditions
Acne Vulgaris
Interventions
Drug: Isotretinoin
Drug: Amzeeq 4% Topical Foam
Subscribe
First Posted Date
2021-06-28
Last Posted Date
2023-06-22
Lead Sponsor
Edward Lain, MD
Target Recruit Count
31
Registration Number
NCT04940767
Locations
🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy